Achieve Life Sciences ACHV
NASDAQ ACHV
$8.49 +0.18 (+2.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

Achieve Life Sciences (ACHV) Asset Utilization Ratio (2011 - 2016)

Achieve Life Sciences' (ACHV) quarterly Asset Utilization Ratio came in at 0.37 in Q1 2016, up 12.89% YoY from 0.33 in Q2 2015, and up 28.3% on a QoQ basis from 0.29 in Q4 2015.

Analysis

Achieve Life Sciences (ACHV) Asset Utilization Ratio (2011 - 2016) Analysis & Trends

Achieve Life Sciences (ACHV) has 6 years of Asset Utilization Ratio data on file, last reported at 0.37 in Q1 2016.

  • Quarterly Asset Utilization Ratio rose 12.89% year-over-year to 0.37 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was 0.37 (up 12.89% YoY) and the FY2015 annual result came in at 0.32, down 34.5% from the prior year.
  • Asset Utilization Ratio grew to 0.37 in Q1 2016, from 0.29 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.71 in Q2 2014 to a low of 0.06 in Q2 2012.
  • A 5-year average of 0.36 and a median of 0.33 in 2015 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2013 — Asset Utilization Ratio surged 596.14% — and 2015, when it sank 59.05%.
  • Tracing ACHV's Asset Utilization Ratio over 5 years: stood at 0.22 in 2012, then soared by 127.11% to 0.51 in 2013, then dropped by 10.49% to 0.46 in 2014, then sank by 37.0% to 0.29 in 2015, then grew by 28.3% to 0.37 in 2016.
  • The last three Asset Utilization Ratio figures came in at 0.37 (Q1 2016), 0.29 (Q4 2015), and 0.27 (Q3 2015), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.38
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 0.20
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 0.69
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 0.90
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.13
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.54
10 Achieve Life Sciences 369.90 Mn 369.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 0.37
Dec 31, 2015 0.29
Sep 30, 2015 0.27
Jun 30, 2015 0.29
Mar 31, 2015 0.33
Dec 31, 2014 0.46
Sep 30, 2014 0.54
Jun 30, 2014 0.71
Mar 31, 2014 0.69
Dec 31, 2013 0.51
Sep 30, 2013 0.47
Jun 30, 2013 0.38
Mar 31, 2013 0.30
Dec 31, 2012 0.22
Sep 30, 2012 0.11
Jun 30, 2012 0.06
Mar 31, 2012 0.06
Dec 31, 2011 0.08
Sep 30, 2011 0.09